COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type is a research paper published in Arteriosclerosis Thrombosis and Vascular Biology (2024). On theSindex it has a DataRank of 0. It has been cited 62 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: U54 HL170326
NHLBI NIH HHS
Grant: R01 HL148110
NHLBI NIH HHS
Grant: R01 HL168493
NHLBI NIH HHS
Grant: P01 HL147823
NIEHS NIH HHS
Grant: P30 ES007048
National Institutes of Health
Grant: 1R01DK132735-01
Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity
National Institutes of Health
Grant: 5R01HL147883-02
Systems genetics approach to inflammatory mechanisms in atherosclerosis
National Institutes of Health
Grant: 5R01HL148110-04
Biological Mechanisms through which TMAO Promotes Atherosclerosis
National Institutes of Health
Grant: 5P01HL147823-03
Gut Microbiota and Cardiometabolic Diseases
National Institutes of Health
Grant: 5P30ES007048-17
Pilot Project Program
National Institutes of Health
Grant: 7R01HL168493-02
Genetic Predisposition to Myocardial Infarction in Patients with Coronary Artery Disease
Influential Citations
1
Fields of Study
MeSH Terms
Keywords